| Advanz Pharma Specialty Medicine Switzerland GmbH - Gobivaz 50 mg/ 0.5 ml, Injektionslösung im Fertigpen |
| 70711 | | 02 | | Gobivaz 50 mg/ 0.5 ml | | Injektionslösung im Fertigpen | | L04AB06 | | Golimumab | | 30.07.2026 | | |
|
| Composition |
| golimumabum 50 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 20.5 mg, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
| Packungsbestandteile |
| Injektionslösung im Fertigpen | | | | | | Active Agent | Dose |
|---|
| Golimumabum | 50mg / 0.5ml |
| | | | Inactive agents | Dose |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Poloxamer | 188 | | Sorbitol | 20.5mg / 0.5ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | B | | Yes | | 002 | 3 | | | B | | Yes |
|
